[Study of the cases with multidrug-resistant Pseudomonas aeruginosa by sputum culture].
We evaluated the clinical features of multidrug-resistant Pseudomonas aeruginosa cases determined by sputum culture between April, 2005 and December, 2006. The clinical features of most cases were: (1) pneumonia in the elderly with cerebrovascular diseases, (2) previous administration of carbapenems and antipseudomonal cephems, (3) PIPC, CAZ and ISP sensitve MDRP, (4) MRSA was isolated concurrently, (5) not necessary of therapy against MDRP, (6) good outcome.
Okimoto
Niro
N
Center for Respiratory Diseases, Kawasaki Medical School Kawasaki Hospital.
Nanba
Fumiyo
F
Kibayashi
Takashi
T
Kishimoto
Michihiro
M
Yamato
Kenji
K
Kurihara
Takeyuki
T
Honda
Yoshihiro
Y
Osaki
Kohichi
K
Asaoka
Naoko
N
D000328:Adult; D000368:Aged; D000583:Amikacin / Q000494:pharmacology; D015377:Cilastatin / Q000494:pharmacology; D000077728:Cilastatin, Imipenem Drug Combination; D002939:Ciprofloxacin / Q000494:pharmacology; D004338:Drug Combinations; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006785:Hospitals, University; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D007564:Japan; D007711:Klebsiella pneumoniae / Q000302:isolation & purification; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000382:microbiology*; D011379:Prognosis; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*; D012189:Retrospective Studies; D013183:Sputum / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000302:isolation & purification; D013997:Time Factors
D004338:Drug Combinations; D015377:Cilastatin; D002939:Ciprofloxacin; D015378:Imipenem; D000583:Amikacin; D000077728:Cilastatin, Imipenem Drug Combination